Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1333

1.

A LEADER in the management of type 2 diabetes and cardiorenal disease.

Verma S, Leiter LA, Latter DA, Bhatt DL.

J Thorac Cardiovasc Surg. 2019 Jun 18. pii: S0022-5223(19)31021-9. doi: 10.1016/j.jtcvs.2019.03.134. [Epub ahead of print] No abstract available.

PMID:
31227180
2.

The rise and fall of aspirin in the primary prevention of cardiovascular disease.

Raber I, McCarthy CP, Vaduganathan M, Bhatt DL, Wood DA, Cleland JGF, Blumenthal RS, McEvoy JW.

Lancet. 2019 May 25;393(10186):2155-2167. doi: 10.1016/S0140-6736(19)30541-0. Review.

PMID:
31226053
3.

Efficacy and Safety with Ticagrelor in Patients with Prior Myocardial Infarction in the Approved European label: Insights from PEGASUS-TIMI 54.

Dellborg M, Bonaca MP, Storey RF, Steg PG, Im KA, Cohen M, Bhatt DL, Ophuis TO, Budaj A, Hamm C, Spinar J, Kiss RG, Lopez-Sendon J, Kamensky G, Van de Werf F, Ardissino D, Kontny F, Montalescot G, Johanson P, Bengtsson O, Himmelmann A, Braunwald E, Sabatine MS.

Eur Heart J Cardiovasc Pharmacother. 2019 Jun 20. pii: pvz020. doi: 10.1093/ehjcvp/pvz020. [Epub ahead of print]

PMID:
31218354
4.

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.

Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Gibson CM, Alexander JH.

JAMA Cardiol. 2019 Jun 19. doi: 10.1001/jamacardio.2019.1880. [Epub ahead of print]

PMID:
31215979
5.

Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation.

Li S, Cheng J, Cui L, Gurol ME, Bhatt DL, Fonarow GC, Benjamin EJ, Xing A, Xia Y, Wu S, Gao X.

J Am Heart Assoc. 2019 Jul 2;8(13):e012020. doi: 10.1161/JAHA.119.012020. Epub 2019 Jun 19.

6.

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.

Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ.

JACC Cardiovasc Interv. 2019 Jun 10. pii: S1936-8798(19)30831-3. doi: 10.1016/j.jcin.2019.03.034. [Epub ahead of print] Review.

PMID:
31202949
7.

Interventions for secondary mitral regurgitation in patients with heart failure: A network meta-analysis of randomized controlled comparisons of surgery, medical therapy & transcatheter intervention.

Kheiri B, Zayed Y, Barbarawi M, Osman M, Chahine A, Ahmed S, Bachuwa G, Hassan M, Alkhouli M, Feldman T, Bhatt DL.

Cardiovasc Revasc Med. 2019 Apr 17. pii: S1553-8389(19)30234-9. doi: 10.1016/j.carrev.2019.04.008. [Epub ahead of print]

PMID:
31201060
8.

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.

Mosenzon O, Wiviott SD, Cahn A, Rozenberg A, Yanuv I, Goodrich EL, Murphy SA, Heerspink HJL, Zelniker TA, Dwyer JP, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Kato ET, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS, Raz I.

Lancet Diabetes Endocrinol. 2019 Jun 10. pii: S2213-8587(19)30180-9. doi: 10.1016/S2213-8587(19)30180-9. [Epub ahead of print]

PMID:
31196815
9.

Aspirin for Primary Prevention of Cardiovascular Events.

Abdelaziz HK, Saad M, Pothineni NVK, Megaly M, Potluri R, Saleh M, Kon DLC, Roberts DH, Bhatt DL, Aronow HD, Abbott JD, Mehta JL.

J Am Coll Cardiol. 2019 Jun 18;73(23):2915-2929. doi: 10.1016/j.jacc.2019.03.501.

PMID:
31196447
10.

More CREDENCE for SGLT2 Inhibition.

Verma S, Bhatt DL.

Circulation. 2019 Jun 11. doi: 10.1161/CIRCULATIONAHA.119.041181. [Epub ahead of print]

PMID:
31181959
11.

Coronary embolism: A systematic review.

Lacey MJ, Raza S, Rehman H, Puri R, Bhatt DL, Kalra A.

Cardiovasc Revasc Med. 2019 May 22. pii: S1553-8389(19)30311-2. doi: 10.1016/j.carrev.2019.05.012. [Epub ahead of print] Review.

PMID:
31178350
12.

Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD).

Arnold SV, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Mues KE, Alam S, Elliott-Davey M, Bhatt DL, Cannon CP, Kosiborod M; GOULD Investigators.

Circulation. 2019 Jun 7. doi: 10.1161/CIRCULATIONAHA.119.041730. [Epub ahead of print]

PMID:
31174429
13.

Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.

Branch KR, Probstfield JL, Eikelboom JW, Bosch J, Maggioni AP, Cheng RK, Bhatt DL, Avezum A, Fox KAA, Connolly SJ, Shestakovska O, Yusuf S.

Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609. [Epub ahead of print]

PMID:
31163978
14.

Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS investigators.

Gastroenterology. 2019 May 29. pii: S0016-5085(19)40974-8. doi: 10.1053/j.gastro.2019.05.056. [Epub ahead of print]

PMID:
31152740
15.

Trends in elective and ruptured abdominal aortic aneurysm repair by practice setting in Ontario, Canada, from 2003 to 2016: a population-based time-series analysis.

Salata K, Hussain MA, de Mestral C, Greco E, Aljabri BA, Sabongui S, Mamdani M, Forbes TL, Bhatt DL, Verma S, Al-Omran M.

CMAJ Open. 2019 May 30;7(2):E379-E384. doi: 10.9778/cmajo.20180173. Print 2019 Apr-Jun.

16.

Endoscopic versus Open Vein-Graft Harvesting for CABG. Reply.

Zenati MA, Bhatt DL, Stock EM.

N Engl J Med. 2019 May 30;380(22):e43. doi: 10.1056/NEJMc1904533. No abstract available.

PMID:
31141653
17.

Longitudinal Trajectories of Hospital Performance across Targeted Cardiovascular Conditions in the United States.

Vaduganathan M, McCarthy CP, Ayers C, Bhatt DL, Kumbhani DJ, de Lemos JA, Fonarow GC, Pandey A.

Eur Heart J Qual Care Clin Outcomes. 2019 May 24. pii: qcz026. doi: 10.1093/ehjqcco/qcz026. [Epub ahead of print]

PMID:
31124567
18.

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.

White HD, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Erglis A, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lopes RD, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Sritara P, Tricoci P, Zeiher AM, Schwartz GG.

Eur Heart J. 2019 May 23. pii: ehz299. doi: 10.1093/eurheartj/ehz299. [Epub ahead of print]

PMID:
31121022
19.

Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.

Steg PG, Szarek M, Bhatt DL, Bittner VA, Brégeault MF, Dalby AJ, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Ostadal P, Parkhomenko A, Pordy R, Roe MT, Tricoci P, Vogel R, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Committees and Investigators.

Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038840. [Epub ahead of print]

PMID:
31117810
20.

Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.

Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Chahine A, Haykal T, Kanugula AK, Bachuwa G, Alkotob ML, Bhatt DL.

Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28280. [Epub ahead of print]

PMID:
31111670
21.

A paradoxical relationship between hemoglobin A1C and in-hospital mortality in intracerebral hemorrhage patients.

Dandapat S, Siddiqui FM, Fonarow GC, Bhatt DL, Xu H, Matsouaka R, Heidenreich PA, Xian Y, Schwamm LH, Smith EE.

Heliyon. 2019 May 6;5(5):e01659. doi: 10.1016/j.heliyon.2019.e01659. eCollection 2019 May.

22.

Response by DeFilippis et al to Letter Regarding Article, "Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction: Partners YOUNG-MI Registry".

DeFilippis EM, Singh A, Bhatt DL, Blankstein R.

Circulation. 2019 May 21;139(21):e996. doi: 10.1161/CIRCULATIONAHA.119.040324. No abstract available.

PMID:
31107615
23.

Risk of obstructive coronary artery disease and major adverse cardiac events in patients with noncoronary atherosclerosis: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program.

Gutierrez JA, Bhatt DL, Banerjee S, Glorioso TJ, Josey KP, Swaminathan RV, Maddox TM, Armstrong EJ, Duvernoy C, Waldo SW, Rao SV.

Am Heart J. 2019 Jul;213:47-56. doi: 10.1016/j.ahj.2019.04.004. Epub 2019 Apr 15.

PMID:
31102799
24.

Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.

Singh A, Gupta A, Collins BL, Qamar A, Monda KL, Biery D, Lopez JAG, de Ferranti SD, Plutzky J, Cannon CP, Januzzi JL Jr, Di Carli MF, Nasir K, Bhatt DL, Blankstein R.

J Am Coll Cardiol. 2019 May 21;73(19):2439-2450. doi: 10.1016/j.jacc.2019.02.059.

PMID:
31097165
25.

Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke.

Dodds JA, Xian Y, Sheng S, Fonarow GC, Bhatt DL, Matsouaka R, Schwamm LH, Peterson ED, Smith EE.

Neurology. 2019 Jun 11;92(24):e2784-e2792. doi: 10.1212/WNL.0000000000007653. Epub 2019 May 15.

PMID:
31092622
26.

Targeting RNA to lower triglycerides: long strides from short molecules.

Qamar A, Libby P, Bhatt DL.

Eur Heart J. 2019 May 15. pii: ehz321. doi: 10.1093/eurheartj/ehz321. [Epub ahead of print] No abstract available.

PMID:
31089714
27.

Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.

Wise RA, Chapman KR, Scirica BM, Bhatt DL, Daoud SZ, Zetterstrand S, Reisner C, Gil EG.

JAMA. 2019 May 7;321(17):1693-1701. doi: 10.1001/jama.2019.4973.

PMID:
31063575
28.

Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A, Parkhomenko A, Ryden L, Pogosova N, Dans A, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne K, Fox KAA, Yusuf S; COMPASS investigators.

Gastroenterology. 2019 May 2. pii: S0016-5085(19)36764-2. doi: 10.1053/j.gastro.2019.04.041. [Epub ahead of print]

PMID:
31054846
29.

Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk.

Terenzi DC, Trac JZ, Teoh H, Gerstein HC, Bhatt DL, Al-Omran M, Verma S, Hess DA.

Trends Mol Med. 2019 Apr 30. pii: S1471-4914(19)30067-X. doi: 10.1016/j.molmed.2019.03.006. [Epub ahead of print] Review.

PMID:
31053416
30.

Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: A nationwide study.

Aminian A, Aleassa EM, Bhatt DL, Tu C, Khorgami Z, Schauer PR, Brethauer SA, Daigle CR.

Diabetes Obes Metab. 2019 May 3. doi: 10.1111/dom.13765. [Epub ahead of print]

PMID:
31050119
31.

Temporal Trends and Outcomes of Hospitalizations With Prinzmetal Angina: Perspectives From a National Database.

Elbadawi A, Elgendy IY, Naqvi SY, Mohamed AH, Ogunbayo GO, Omer MA, Mentias A, Saad M, Abbott JD, Jneid H, Bhatt DL.

Am J Med. 2019 Apr 29. pii: S0002-9343(19)30342-0. doi: 10.1016/j.amjmed.2019.04.005. [Epub ahead of print]

PMID:
31047867
32.

Stability After Initial Decline in Coronary Revascularization Rates in the United States.

Raza S, Deo SV, Kalra A, Zia A, Altarabsheh SE, Deo VS, Mustafa RR, Younes A, Rao SV, Markowitz AH, Park SJ, Costa MA, Simon DI, Bhatt DL, Sabik JF 3rd.

Ann Thorac Surg. 2019 Apr 27. pii: S0003-4975(19)30596-X. doi: 10.1016/j.athoracsur.2019.03.080. [Epub ahead of print]

PMID:
31039350
33.

Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus.

Ehrlich ME, Liang L, Xu H, Kosinski AS, Hernandez AF, Schwamm LH, Smith EE, Fonarow GC, Bhatt DL, Peterson ED, Xian Y.

Stroke. 2019 Jun;50(6):1497-1503. doi: 10.1161/STROKEAHA.118.024172. Epub 2019 Apr 30.

PMID:
31035901
34.

Corrigendum to `Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States☆' [The American Journal of Cardiology 123/7 (2019) 1187-1189].

Gupta T, Khera S, Kolte D, Goel K, Villablanca PA, Abbott JD, Fonarow GC, Rihal CS, Garcia MJ, Bhatt DL, Latib A, Weisz G.

Am J Cardiol. 2019 Jul 1;124(1):168. doi: 10.1016/j.amjcard.2019.04.001. Epub 2019 Apr 26. No abstract available.

PMID:
31030968
35.

Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program.

McCarthy CP, Vaduganathan M, Patel KV, Lalani HS, Ayers C, Bhatt DL, Januzzi JL Jr, de Lemos JA, Yancy C, Fonarow GC, Pandey A.

JAMA Netw Open. 2019 Apr 5;2(4):e192987. doi: 10.1001/jamanetworkopen.2019.2987.

36.

Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement.

Mohananey D, Villablanca P, Gupta T, Ranka S, Bhatia N, Adegbala O, Ando T, Wang DD, Wiley JM, Eng M, Kalra A, Ramakrishna H, Shah B, O'Neill W, Saucedo J, Bhatt DL.

Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28310. [Epub ahead of print]

PMID:
31025488
37.

Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.

Bhatt DL, Steg PG, Miller M.

N Engl J Med. 2019 Apr 25;380(17):1678. doi: 10.1056/NEJMc1902165. No abstract available.

PMID:
31018077
38.

Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis.

Mavrakanas TA, Chatzizisis YS, Gariani K, Kereiakes DJ, Gargiulo G, Helft G, Gilard M, Feres F, Costa RA, Morice MC, Georges JL, Valgimigli M, Bhatt DL, Mauri L, Charytan DM.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):810-822. doi: 10.2215/CJN.12901018. Epub 2019 Apr 22.

PMID:
31010936
39.

Drug-eluting stents versus bare-metal stents with a single month of dual antiplatelet therapy: a trial sequential analysis.

Kheiri B, Bachuwa G, Bhatt DL.

J Thromb Thrombolysis. 2019 Jul;48(1):11-13. doi: 10.1007/s11239-019-01861-6. No abstract available.

PMID:
30993516
40.

Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53.

Zelniker TA, Morrow DA, Mosenzon O, Gurmu Y, Im K, Cahn A, Raz I, Steg PG, Leiter LA, Braunwald E, Bhatt DL, Scirica BM.

Clin Chem. 2019 Jun;65(6):781-790. doi: 10.1373/clinchem.2018.298489. Epub 2019 Apr 15.

PMID:
30988169
41.

REDUCE-IT.

Bhatt DL.

Eur Heart J. 2019 Apr 14;40(15):1174-1175. doi: 10.1093/eurheartj/ehz179. No abstract available.

PMID:
30982067
42.

Outcomes and Resource Utilization for Nonelective Versus Elective Transcatheter Mitral Valve Repair.

Alkhouli M, Alqahtani F, Bhatt DL, Mathew V.

Am J Cardiol. 2019 Jun 1;123(11):1889-1891. doi: 10.1016/j.amjcard.2019.03.034. Epub 2019 Mar 20. No abstract available.

PMID:
30981420
43.

Meta-analysis of Percutaneous Coronary Intervention Versus Medical Therapy in the Treatment of Coronary Chronic Total Occlusion.

Barbarawi M, Kheiri B, Zayed Y, Gakhal I, Barbarawi O, Rashdan L, Osman M, Bachuwa G, Alkotob ML, Bhatt DL.

Am J Cardiol. 2019 Jun 15;123(12):2060-2062. doi: 10.1016/j.amjcard.2019.03.032. Epub 2019 Mar 18. No abstract available.

PMID:
30967287
44.

Comparison of Sex-Based Differences in Home or Nonhome Discharge Utilization of Rehabilitative Services and Outcomes Following Transcatheter Aortic Valve Implantation in the United States.

Shah RM, Hirji SA, Jolissaint JS, Lander HL, Shah PB, Pelletier MP, Sobieszczyk PS, Berry NC, Shook DC, Nyman CB, Bhatt DL, Body S, Kaneko T.

Am J Cardiol. 2019 Jun 15;123(12):1983-1991. doi: 10.1016/j.amjcard.2019.03.008. Epub 2019 Mar 19.

PMID:
30952379
45.

Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension.

Sardar P, Bhatt DL, Kirtane AJ, Kennedy KF, Chatterjee S, Giri J, Soukas PA, White WB, Parikh SA, Aronow HD.

J Am Coll Cardiol. 2019 Apr 9;73(13):1633-1642. doi: 10.1016/j.jacc.2018.12.082.

PMID:
30947915
46.

Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry.

Jogu HR, Arora S, Vaduganathan M, Qamar A, Pandey A, Chevli PA, Pansuriya TH, Ahmad MI, Dutta A, Sunkara PR, Qureshi W, Vasu S, Upadhya B, Bhatt DL, Januzzi JL Jr, Herrington D.

Clin Cardiol. 2019 Jun;42(6):592-604. doi: 10.1002/clc.23182. Epub 2019 Apr 12.

47.

Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial.

Lip GYH, Mauri L, Montalescot G, Ozkor M, Vardas P, Steg PG, Bhatt DL, Hohnloser SH, Miede C, Nordaby M, Brueckmann M, Kreuzer J, Kimura T, Oldgren J, Ten Berg JM, Cannon CP.

Am Heart J. 2019 Jun;212:13-22. doi: 10.1016/j.ahj.2019.02.006. Epub 2019 Mar 1.

PMID:
30928824
48.

One- to 10-Day Versus 11- to 30-Day All-Cause Readmission and Mortality in Older Patients With Heart Failure.

Lam PH, Dooley DJ, Arundel C, Morgan CJ, Fonarow GC, Bhatt DL, Allman RM, Ahmed A.

Am J Cardiol. 2019 Jun 1;123(11):1840-1844. doi: 10.1016/j.amjcard.2019.03.007. Epub 2019 Mar 13.

PMID:
30928031
49.

Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.

Vaduganathan M, Patel RB, Singh A, McCarthy CP, Qamar A, Januzzi JL Jr, Scirica BM, Butler J, Cannon CP, Bhatt DL.

J Am Coll Cardiol. 2019 Apr 2;73(12):1596-1598. doi: 10.1016/j.jacc.2019.01.029. No abstract available.

PMID:
30922481
50.

Arterial Inflammation: The Heat Before the Storm.

Blankstein R, Libby P, Bhatt DL.

J Am Coll Cardiol. 2019 Apr 2;73(12):1383-1385. doi: 10.1016/j.jacc.2019.02.002. No abstract available.

PMID:
30922469

Supplemental Content

Loading ...
Support Center